by Single Cell Genome Sequencing is a process that enables analysis of DNA and RNA from individual cells. This technique is revolutionizing biological research by enabling exploration of cell types, cell states, and cell-to-cell variations within a population. It allows researchers to investigate how genetic or epigenetic changes in individual cells impact cell functions, development of diseases and response to treatment.
The global Single Cell Genome Sequencing Market is estimated to be valued at US$ 2.63 Mn in 2024 and is expected to exhibit a CAGR of 3.9% over the forecast period from 2024 to 2030.
Key Takeaways
Key players operating in the single cell genome sequencing market are Logitech International SA, Microsoft Corporation, Datadesk Technologies, Inc., Fentek Industries Inc., Adesso AG, Shenzhen V4 Electronic Co., Ltd., Fellowes Limited, Kinesis Corporation, Gold Touch Enterprise Inc., and Posturite UK Ltd.
The growing demand for precision medicine, stem cell research, disease diagnosis, and cancer research is propelling the Single Cell Genome Sequencing Market Growth. The availability of advanced genome sequencing instruments and kits along with reduction in sequencing costs is fueling the adoption of single cell genome sequencing. Leading market players are expanding their presence globally through collaborations with research institutes and hospitals to increase the accessibility of single cell genome sequencing solutions.
Market Key Trends
Artificial intelligence is playing a key role in driving innovations in single cell genome sequencing. AI-powered algorithms and computing are enabling analysis of massive datasets generated through single cell genome sequencing. AI is helping researchers identify cell types and subtypes, reconstruct lineages of cells, determine factors regulating gene expression, and map cellular pathways and networks. AI-guided analysis is accelerating biological research by providing insights into complex cellular behaviors, molecular regulation within individual cells, cell heterogeneity, and development of diseases at single cell resolution. This is expected to fuel the demand for AI-driven single cell genome sequencing solutions.
Porter’s Analysis
Threat of new entrants: Medium, requiring significant capital investment in infrastructure and specialized talent; However, market space for niche applications is growing.
Bargaining power of buyers: Medium, with number of providers to chose from but buyers have demand for customized solutions
Bargaining power of suppliers: Low, suppliers of instruments, consumables and reagents fragmented with no dominant players
Threat of new substitutes: Low, no direct technology substitutes on the horizon
Competitive rivalry: High, market characterized by continuous product and technology innovation among well-funded players to gain competitive advantage.
Geographical Regions
North America currently holds the largest share of the single cell genome sequencing market in terms of value, mainly attributed to presence of major industry players and availability of research funds supporting development of advanced sequencing technologies.
The Asia Pacific region is poised to witness the fastest growth over the forecast period, led by increasing private and public investments in life science research. Establishing new research centers and genome sequencing applications in precision medicine are some factors driving market growth in countries like China and India.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
